IP Library Assignment 052500/0211
Patent Assignment
Reel/Frame 052500/0211

Assignment of Assignor's Interest

Recorded: 2020-04-27 Pages: 9
Assignors
XU, YONG
Executed: 2014-01-28
BRENNING, BENJAMIN GARY
Executed: 2014-04-30
KULTGEN, STEVEN G.
Executed: 2014-01-28
LIU, XIAOHUI
Executed: 2014-02-05
SAUNDERS, MICHAEL
Executed: 2014-03-12
HO, KOC-KAN
Executed: 2014-04-17
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Properties (3)
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Application: 15/207,224 →
Publication: US 2017/0002014
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Application: 16/033,038 →
Publication: US 2019/0071446
Substituted Imidazo[1,2-B]Pyridazines as Protein Kinase Inhibitors
Application: 16/460,755 →
Publication: US 2020/0102313
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest Nov 17, 2016
From: TOLERO PHARMACEUTICALS, INC.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 040362/0884 →
Merger Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0940 →
Change of Name Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0718 →
Change of Name Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →
Merger Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →